- Home
- INDI vs MREO Comparison
INDI vs MREO Comparison
Compare INDI & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDI
- MREO
- Stock Information
- Founded
- INDI 2007
- MREO 2015
- Country
- INDI United States
- MREO United Kingdom
- Employees
- INDI N/A
- MREO N/A
- Industry
- INDI Semiconductors
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- INDI Technology
- MREO Health Care
- Exchange
- INDI Nasdaq
- MREO Nasdaq
- Market Cap
- INDI 471.6M
- MREO 424.5M
- IPO Year
- INDI N/A
- MREO N/A
- Fundamental
- Price
- INDI $3.17
- MREO $2.85
- Analyst Decision
- INDI Strong Buy
- MREO Strong Buy
- Analyst Count
- INDI 6
- MREO 7
- Target Price
- INDI $5.75
- MREO $7.71
- AVG Volume (30 Days)
- INDI 4.0M
- MREO 1.2M
- Earning Date
- INDI 08-07-2025
- MREO 08-12-2025
- Dividend Yield
- INDI N/A
- MREO N/A
- EPS Growth
- INDI N/A
- MREO N/A
- EPS
- INDI N/A
- MREO N/A
- Revenue
- INDI $218,406,000.00
- MREO N/A
- Revenue This Year
- INDI $7.46
- MREO N/A
- Revenue Next Year
- INDI $32.80
- MREO $54.07
- P/E Ratio
- INDI N/A
- MREO N/A
- Revenue Growth
- INDI N/A
- MREO N/A
- 52 Week Low
- INDI $1.53
- MREO $1.58
- 52 Week High
- INDI $7.45
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- INDI 58.18
- MREO 64.74
- Support Level
- INDI $3.13
- MREO $2.61
- Resistance Level
- INDI $3.56
- MREO $2.85
- Average True Range (ATR)
- INDI 0.25
- MREO 0.17
- MACD
- INDI 0.01
- MREO 0.03
- Stochastic Oscillator
- INDI 56.60
- MREO 88.83
About INDI indie Semiconductor Inc.
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for advanced Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).